The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery
Clinical trial NCT01606111 · TERMINATED
Trial details
- NCT number
- NCT01606111
- Sponsor
- Ever Neuro Pharma GmbH
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-07-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.